Zavegepant is a small molecule calcitonin gene-related peptide (CGRP) receptor antagonist. CGRP is a protein involved in transmitting pain signals in the brain.
Zavegepant’s nasal formulation could be particularly valuable for migraine patients who experience nausea and difficulty swallowing.Zavegepant is now a Pfizer asset
Pfizer (NYSE:PFE) acquired the asset through last year’s purchase of Biohaven Pharmaceutical Holding Company (NYSE:BHVN), which had commercialized the dual-acting migraine therapy Nurtec ODT (rimegepant).
In the recent …